BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2230926
,
PPARA
,
Angiogenesis
,
Pseudomonas infection
,
Kidney
,
Neocentromeres
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
braf protein, human
(compound)
NextBio Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Melanoma cells Ras or BRAF mutant treated with sorafenib and/or diclofenac
Antitumor efficacy of GDC-0879 involving BRAF mutational status
Response to TNF-alpha in melanoma cell lines with different mutations
Gene expression in response to chemotherapy in human-melanoma cells
Uveal melanoma cell lines reponses to selumetinib treatment
Explore Curated Studies Results
Literature
Most Relevant Literature
BRAF V600E mutated metastatic colorectal cancer: current progress and future directions.
Targeting BRAF-mutant glioma: reflections on the ROAR trial.
BRAF inhibitors-induced paradoxical reactions and oncogenesis].
BRAF: a biomarker not to be missed in glioblastoma.
Myocarditis as a manifestation of Erdheim-Chester Disease: successful use of anti- IL1 and BRAF inhi…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations
Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Dis…
HDAC Inhibitor Vorinostat in Resistant BRAF V600 Mutated Advanced Melanoma
GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma
Trametinib in Treating Patients With Advanced Melanoma With BRAF Non-V600 Mutations
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ